Search
for
Sort by
Research 271–300 of 958
- Chinese SLE Treatment and Research group (CSTAR) registry 2009–2019: Major clinical characteristics of Chinese patients with systemic lupus erythematosus
- Delayed treatment leading to multisystem complications in a child with SLE
- Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
- Hair diameter in systemic lupus erythematosus
- C85. Right heart failure due to chronic thromboembolic pulmonary hypertension in systemic lupus erythematosus patient: a case report
- AB0987 ANIFROLUMAB TREATMENT IMPROVES QUALITY OF LIFE AND DECREASES SYSTEMIC CORTICOSTEROID USE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Hair product use in systemic lupus erythematosus. A case‐control study
- Selective complete Clq deficiency associated with systemic lupus erythematosus.
- Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- OA08 Ocrelizumab in pregnancy in a patient with juvenile onset systemic lupus erythematosus
- HAIR AND SYSTEMATIC DISEASE
- SLE classification criteria item relationships: implications on SLE as a disease entity
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- A Neglected case of Systemic lupus erythematosus presenting by Degos’ skin disease and diffuse non-scarring alopecia with dramatic response to treatment, clinically and dermoscopy.
- Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice
- Generalized maculopapular rash and fever
- Medical dermatologic conditions in transgender women
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Skin Manifestations of Rheumatological Diseases
- Chemical Synthetic Disease Modifying Drugs (csDMARD) Used forRheumatoid Arthritis
- Iron Deficiency in Immune-Mediated Inflammatory Skin Diseases: A Missing Link Between Systemic Inflammation, Immunometabolism, and Disease Burden
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Research on the correlation between rash and complement C3, C4 levels and the occurrence and development of lupus nephritis
- Association of Anti-Signal Recognition Particle Myopathy with Systemic Lupus Erythematosus
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Alopecias
- Clinical manifestations of cutaneous lupus erythematosus